Finally, they demonstrated the synergistic effect of a combined treatment with PD-1/PD-L1 and phenelzine (a mixed MAO-A/MAO-B inhibitor) on the inhibition of tumor progression in B16-OVA (melanoma) and MC38 (colon cancer) models [100]. Here, MAOB is linked to neoplasm.